Shanghai Chenguang Medical Technologies Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shanghai Chenguang Medical Technology Co., Ltd. (securities abbreviation: Chenguang Medical, securities code: 430300) was established in 2004. It is an independent innovative high-tech enterprise and a small giant enterprise in Shanghai that has long been committed to the research and development, production, sales, and maintenance of core components in the high field strength and ultra-high field strength magnetic resonance industry chain. The company has a research and development and production base of over 34000 square meters of high sensitivity magnetic resonance core components in Qingpu Park, Zhangjiang High tech Industrial Development Zone, Shanghai. Its three subsidiaries are Chenshi Medical, Chenzhan Medical, and Chenhao Superconductor. The product covers core components such as RF systems, gradient systems, superconducting magnets for magnetic resonance (1.5T, 3.0T, 7.0T), as well as superconducting, constant-conductive magnets, low-temperature equipment, vacuum semiconductor equipment, etc. The project leaders of Chenguang Medical have rich experience in the development, design, and production of superconducting magnetic resonance core components at home and abroad. The magnetic resonance core components designed and produced by them have been applied to the magnetic resonance systems produced by mainstream MRI companies both domestically and internationally. The magnetic resonance radio frequency detector independently developed and produced by Chenguang Medical has filled the domestic gap when entering the registration of medical device products in China. The company has also customized and developed various experimental specialized radio frequency coils for cutting-edge scientific research. Relying on its leading comprehensive engineering capabilities and years of research and development accumulation, Chenguang Medical has overcome multiple core component technology difficulties in 1.5T, 3.0T, and 7.0T magnetic resonance systems. Currently, 65 patented technologies have been applied to the research and production of magnetic resonance core components, breaking the monopoly of similar international products in China and successfully achieving import substitution. The MR platform solutions provided by the company for Chinese magnetic resonance system manufacturers are comparable to well-known magnetic resonance systems. Chenguang Medical is committed to legal and compliant operations, has established advanced quality system standards, and has obtained admission qualifications for domestic and international markets. The company has successively passed ISO13485, ISO14001, and European CE certification. Our independently developed core products have passed the SFDA certification and UL safety certification of the China Food and Drug Administration. At the same time, products exported to countries such as Europe, the United States, and Japan also have international certifications such as the FDA certification of the US Food and Drug Administration and the PAL certification of Japan. Chenguang Medical will continuously enhance the company's advanced position in the fields of superconducting magnetic resonance radio frequency detectors, superconducting magnets, and gradually expand the industry chain and application fields of superconducting magnetic resonance. It will transform from a component manufacturer to a diversified production and service oriented enterprise, and strive to build "Chenguang Medical" into a Chinese magnetic resonance brand that is comparable to international enterprises. |
| Headquarter | Shanghai |
| Establish Date | 8/3/2004 |
| Listed Code | 430300.BJ |
| Listed Date | 12/7/2022 |
| Chairman | Wang Jie. |
| CEO | Wang Jie. |
| Website | www.shanghaicg.net |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
